ABITREN 100

国家: 以色列

语言: 英文

来源: Ministry of Health

现在购买

公众评估报告 公众评估报告 (PAR)
18-08-2016

有效成分:

DICLOFENAC SODIUM

可用日期:

ABIC LTD.

ATC代码:

M01AB05

药物剂型:

TABLETS SUSTAINED RELEASE

组成:

DICLOFENAC SODIUM 100 MG

给药途径:

PER OS

处方类型:

Required

厂商:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

治疗组:

DICLOFENAC

治疗领域:

DICLOFENAC

疗效迹象:

Rheumatoid arthritis, osteoarthritis, low back pain and other acute musculoskeletal disorders such as periarthritis, tendinitis, tenosynovitis, bursitis, sprains, strains and dislocation, ankylosing spondylitis and acute gout.Control of pain and inflammation in orthopedic, dental, and other minor surgery.

授权日期:

2010-10-31

其他语言的文件

资料单张 资料单张 希伯来文 17-08-2016

搜索与此产品相关的警报

查看文件历史